The role of nine-valent hpv vaccine

The nine-valent HPV vaccine can prevent HPV6, 11, 16, 18, 31, 33, 45, 52 and 58 infections. It is suitable for the vaccination of women aged 16-26. The nine-valent HPV vaccine is divided into three doses. The vaccination time is according to the immunization program of zero, two and six months. The three doses are completed within six months. It can be extended appropriately, but try not to exceed one week. After vaccination with HPV vaccine, it cannot be said that cervical cancer screening will not be carried out. Cervical cancer screening should be carried out routinely.